Latest updates for Bayry
Fresh curated links around BAYRY are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Bayer: Debt Remains A Problem, Value Remains Compelling
- <![CDATA[Biogen Enters $1 Billion Agreement to Acquire RayThera Inc. ]]>
- ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
pharmexec.com
/3 weeks ago
<![CDATA[Biogen Enters $1 Billion Agreement to Acquire RayThera Inc. ]]>
seekingalpha.com
/1 month ago
ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout
pharmexec.com
/1 week ago
<![CDATA[Novartis to Acquire Myricx Bio for $1.1 Billion]]>
finance.yahoo.com
/1 month ago
Biomarin Pharmaceutical (BMRN): Most Undervalued Stocks to Buy and Hold for 2 Years
cafepharma.com
/1 month ago
Opportunity with Bayer (Diabetes Care)
Opportunity with Bayer (Diabetes Care) Anonymous (not verified) Mon, 06/15/2026 - 20:55 field_thread_url https://cafepharma.com/boards/threads/opportunity-...
cafepharma.com
/1 month ago
BioMarin Pharmaceutical
BioMarin Pharmaceutical Anonymous (not verified) Fri, 06/12/2026 - 17:51 field_thread_url https://cafepharma.com/boards/threads/biomarin-pharmaceutical.710...
cafepharma.com
/3 weeks ago
BioMarin Pharmaceutical
BioMarin Pharmaceutical Anonymous (not verified) Mon, 06/22/2026 - 00:00 field_thread_url https://cafepharma.com/boards/threads/biomarin-pharmaceutical.710...
pharmexec.com
/1 month ago
<![CDATA[Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ]]>
seekingalpha.com
/3 days ago
BridgeBio: "Strong Buy" Attruby Differentiation And Several NDA Submissions In Play
seekingalpha.com
/1 month ago
Barry Callebaut AG (BRRLY) Shareholder/Analyst Call - Slideshow
labiotech.eu
/1 month ago
Blockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026?
Bayer has a lot on its plate; lawsuits, patent cliffs, drug development, and potential FDA approvals. Is it ready to make a comeback in 2026? The post Blockbuster sales, lawsuits,...
pharmexec.com
/3 weeks ago
<![CDATA[AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal]]>
finance.yahoo.com
/1 week ago
R&D Change Underlines Sanofi SA (SNY) Prospects as One of the Best Dividend Stocks to Buy
seekingalpha.com
/1 week ago
Novartis: 'Hold' On Continued Generic Erosion And Need For H2 2026 Catalysts
seekingalpha.com
/1 month ago
Nanobiotix: A Royalty-Backed Physics Platform Hidden Inside A Biotech
cafepharma.com
/1 month ago
Beigene
Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...
finance.yahoo.com
/1 week ago
Pfizer Inc. (PFE): A Top Dividend Stock to Buy According to Hedge Funds amid Ibrance FDA Milestone
finance.yahoo.com
/1 month ago
Abivax Grounded as Cancer Cases Cast a Shadow Over Best-in-Class Trial Data
pharmexec.com
/1 month ago
<![CDATA[Parabilis Medicines Raises $670 Million in Initial Public Offering ]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Bayry
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
labiotech.eu
Recent coverage from public sources
Public source
pharmexec.com
Recent coverage from public sources
Public source